Lansoprazole Bristol Laboratories

Lansoprazole, the active ingredient in Lansoprazole Bristol Laboratories, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, Zollinger‑Ellison syndrome, and as part of Helicobacter pylori eradication regimens, primarily in adult patients.

GNH USA supplies Lansoprazole Bristol Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: accelerates ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid. - Helicobacter pylori eradication regimen: used in combination therapy to improve bacterial eradication rates.

Adverse reactions may occur with Lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated diarrhea: may be severe and persistent. - Low magnesium levels (hypomagnesemia): can cause muscle cramps, seizures, or cardiac arrhythmias.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Review concomitant medications: avoid known contraindicated drugs. - Monitor for signs of infection: especially C. difficile colitis. - Use caution in patients with liver disease: monitor hepatic function. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lansoprazole may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Methotrexate: enhanced toxicity. - Rifampin: decreased Lansoprazole exposure.